United States Nuclear Imaging Equipment Market Outlook to 2020

Publisher Name :
Date: 7-Mar-2014
No. of pages: 85

GlobalData’s new report, “United States Nuclear Imaging Equipment Market Outlook to 2020″, provides key market data on the United States Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Nuclear Imaging Equipment market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Nuclear Imaging Equipment market categories Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United States Nuclear Imaging Equipment market.
  • Key players covered include GE Healthcare, Philips Healthcare and Siemens Healthcare.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

United States Nuclear Imaging Equipment Market Outlook to 2020

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Nuclear Imaging Equipment Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8

3 Nuclear Imaging Equipment Market, United States 10
3.1 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2005-2012 10
3.2 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2012-2020 12
3.2.1 Positron Emission Tomography Systems Market, United States, Revenue ($m), by Segment, 2005-2012 14
3.2.2 Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), by Segment, 2005-2012 16
3.2.3 Positron Emission Tomography Systems Market, United States, Revenue ($m), by Segment, 2012-2020 18
3.2.4 Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), by Segment, 2012-2020 20
3.3 Nuclear Imaging Equipment Market, United States, Volume (Units), 2005-2012 22
3.4 Nuclear Imaging Equipment Market, United States, Volume (Units), 2012-2020 24
3.4.1 Positron Emission Tomography Systems Market, United States, Volume (Units), by Segment, 2005-2012 26
3.4.2 Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), by Segment, 2005-2012 28
3.4.3 Positron Emission Tomography Systems Market, United States, Volume (Units), by Segment, 2012-2020 30
3.4.4 Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), by Segment, 2012-2020 32
3.5 Nuclear Imaging Equipment Market, United States, Average Price ($), 2005-2020 34
3.6 Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), 2011-2012 36
3.7 Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2011-2012 37

4 Overview of Key Companies in United States, Nuclear Imaging Equipment Market 39
4.1 Philips Healthcare 39
4.1.1 Company Overview 39
4.2 GE Healthcare 39
4.2.1 Company Overview 39
4.3 Siemens Healthcare 40
4.3.1 Company Overview 40

5 Nuclear Imaging Equipment Market Pipeline Products 41

6 Financial Deals Landscape 42
6.1 Acquisition 42
6.1.1 Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million 42
6.1.2 BC Technical Acquires Nuclear Cardiology Systems, Provider Of Nuclear Medical Services 44
6.1.3 BC Technical Completes Acquisition Of Genesis Medical Imaging 45
6.1.4 BC Technical Acquires Xpert, Molecular Imaging Service Company 46
6.2 Asset Transactions 47
6.2.1 Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For US$3 Million 47
6.3 Equity Offerings 49
6.3.1 LipoScience Completes IPO For US$52 Million 49
6.4 Partnerships 51
6.4.1 Positron And Biologics Modular Enter Into Co-Marketing Agreement For PosiRx System 51

7 Recent Developments 52
7.1 Corporate Communications 52
7.1.1 Feb 25, 2014: Molecular Imaging Services Appoints Dr. Gary Heller as Chief Medical Officer 52
7.1.2 Jan 22, 2014: LipoScience Announces Appointment of Howard Doran as President and Chief Executive Officer 52
7.1.3 Sep 06, 2013: LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer 53
7.1.4 Aug 09, 2013: LipoScience Announces Appointment Of Vice President, General Counsel And Corporate Secretary 54
7.1.5 Aug 08, 2013: LipoScience Announces Two New Members of Board of Directors 54
7.1.6 Aug 02, 2013: LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer 55
7.1.7 Jul 11, 2013: Lantheus Medical Imaging Announces Chief Financial Officer Transition 55
7.1.8 Jul 01, 2013: Matthew G. Molchan Assumes the CEO Role at Digirad 56
7.1.9 Mar 06, 2013: Lantheus Medical Imaging Appoints Cesare Orlandi As CMO 56
7.2 Financial Announcements 57
7.2.1 Feb 26, 2014: Digirad Reports Fourth Quarter and Year-End Financial Results 57
7.2.2 Feb 03, 2014: Digirad Announces Quarterly Dividend of $0.05 Per Share 58
7.2.3 Jan 24, 2014: Gagnon Cardiovascular Institute At Morristown Medical Center Implants Newly Approved Device To Replace Failing Aortic Heart Valves 59
7.2.4 Nov 21, 2013: LipoScience to Discuss 2014 Guidance on Fourth Quarter 2013 Financial Results Conference Call 61
7.2.5 Nov 06, 2013: Lantheus Medical Imaging to Host Third Quarter 2013 Conference Call on November 13, 2013 at 3:00 p.m. Eastern Time 61
7.2.6 Nov 05, 2013: LipoScience Reports Third Quarter 2013 Financial Results 61
7.2.7 Oct 22, 2013: LipoScience to Release Third Quarter Fiscal Year 2013 Financial Results 63
7.2.8 Oct 15, 2013: Digirad to Release 2013 Third Quarter and Nine-Month Financial Results on November 1, 2013 63
7.2.9 Aug 06, 2013: LipoScience Reports Second Quarter 2013 Financial Results 63
7.2.10 Aug 01, 2013: Lantheus Medical Imaging to Host Second Quarter 2013 Conference Call on August 8, 2013 at 4:00 p.m. Eastern Time 65
7.2.11 Aug 01, 2013: Digirad Corporation Reports Second Quarter and Six-Month Financial Results 65
7.2.12 Jul 23, 2013: LipoScience to Release Second Quarter Fiscal Year 2013 Financial Results 67
7.2.13 Jul 18, 2013: Digirad Corporation to Release 2013 Second Quarter and Six-Month Financial Results on August 1, 2013 67
7.2.14 May 09, 2013: LipoScience Reports Revenue Of $13.6m In Q1 2013 67
7.2.15 May 06, 2013: Digirad Corporation Reports First Quarter Financial Results 69
7.2.16 Mar 27, 2013: LipoScience Reports Revenue Of $54.8m In 2012 70
7.3 Government and Public Interest 72
7.3.1 Nov 27, 2013: LipoScience to present at 25th Annual Piper Jaffray Healthcare Conference 72
7.3.2 Nov 27, 2013: LipoScience to Present at 25th Annual Piper Jaffray Healthcare Conference 73
7.3.3 Nov 14, 2013: Digirad to present at the 6th annual LD MICRO conference 73
7.3.4 Sep 10, 2013: Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 19, 2013 73
7.3.5 Aug 02, 2013: Digirad to Present at the 2013 Southern California Investor Conference 73
7.4 Other Significant Developments 74
7.4.1 Jan 22, 2014: Nanotherapeutics selects GE Healthcare Life Sciences technologies for Advanced Development and Manufacturing Center 74
7.4.2 Nov 13, 2013: NGAGE Announces Representation Agreement with SIEMENS Healthcare 74
7.4.3 Sep 09, 2013: Digirad Signs Agreement to Outsource Imaging Equipment Manufacturing 75
7.4.4 Mar 19, 2013: Lantheus Medical Imaging Announces Molybdenum-99 Supply Contract With IRE 75
7.5 Strategy And Business Planning 76
7.5.1 Mar 21, 2013: Lantheus Announces Corporate Plans 76

8 Appendix 77
8.1 Research Methodology 78
8.1.1 Coverage 78
8.1.2 Secondary Research 78
7.1.3 Primary Research 79
8.1.4 Market Modeling and Forecasting 80
8.1.5 Company Share Analysis 83
8.1.6 Distribution Share Analysis 84
8.2 Expert Panel 85
8.3 GlobalData Consulting 85
8.4 Contact Us 85
8.5 Disclaimer 85

List of Tables

Table 1: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 11
Table 2: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Table 3: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 15
Table 4: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 17
Table 5: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 19
Table 6: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 21
Table 7: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2005-2012 23
Table 8: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2012-2020 25
Table 9: Positron Emission Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 27
Table 10: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 29
Table 11: Positron Emission Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 31
Table 12: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 33
Table 13: Nuclear Imaging Equipment Market, United States, Average Price ($), Historic, 2005-2012 34
Table 14: Nuclear Imaging Equipment Market, United States, Average Price ($), Forecast, 2012-2020 35
Table 15: Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 36
Table 16: Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 38
Table 17: Nuclear Imaging Equipment Market Pipeline Products 41
Table 18: Biosensors International Completes Acquisition Of Spectrum Dynamics For US$72.5 Million 42
Table 19: BC Technical Acquires Nuclear Cardiology Systems, Provider Of Nuclear Medical Services 44
Table 20: BC Technical Completes Acquisition Of Genesis Medical Imaging 45
Table 21: BC Technical Acquires Xpert, Molecular Imaging Service Company 46
Table 22: Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For US$3 Million 47
Table 23: LipoScience Completes IPO For US$52 Million 49
Table 24: Positron And Biologics Modular Enter Into Co-Marketing Agreement For PosiRx System 51
Table 25: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country 80

List of Figures

Figure 1: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 10
Figure 2: Nuclear Imaging Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 12
Figure 3: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 14
Figure 4: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 16
Figure 5: Positron Emission Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 18
Figure 6: Single Photon Emission Computed Tomography Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 20
Figure 7: Nuclear Imaging Equipment Market, United States, Volume (Units), Historic, 2005-2012 22
Figure 8: Nuclear Imaging Equipment Market, United States, Volume (Units), Forecast, 2012-2020 24
Figure 9: Positron Emission Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 26
Figure 10: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Historic, 2005-2012 28
Figure 11: Positron Emission Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 30
Figure 12: Single Photon Emission Computed Tomography Systems Market, United States, Volume (Units), Forecast, 2012-2020 32
Figure 13: Nuclear Imaging Equipment Market, United States, Company Share (%), 2012 37
Figure 14: GlobalData Epidemiology-Based Forecasting Model 82
Figure 15: GlobalData Capital Equipment-Based Forecasting Model 83
Figure 16: Primary Interviews by Participant Type (%) 84

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Global Pregnancy Detection Card Market 2015-2019
    Published: 19-Nov-2014        Price: US $2500 Onwards        Pages: 71
    Pregnancy detection cards are diagnostic products that check for chemical markers related to pregnancy. The card or cassette format is one of the three categories under rapid pregnancy tests. The remaining two are the strip format and the midstream format. Pregnancy detection cards use the chromatographic immunoassay technique for the detection of hCG in urine to detect pregnancy. The developing placenta produces hCG, which is a glycoprotein hormone, soon after fertilization, and this helps in t......
  • Ultrasound Market by Diagnostic Ultrasound (2D, 3D, 4D, Doppler), Therapeutic Ultrasound (HIFU, ESWL), Products (Cart/Trolley-Based, Compact), Applications (OB/GYN, Cardiac Ultrasound, Vascular Ultrasound, Surgical Ultrasound) – Global Forecast to 2019
    Published: 13-Nov-2014        Price: US $4650 Onwards        Pages: 212
    The global ultrasound market is estimated to grow at a CAGR of 5.1% from 2014 to 2019. Although mature markets such as the U.S., Germany, and the U.K. held larger shares in the ultrasound market in 2014, Asia-Pacific is poised to grow at the highest CAGR of 5.5% in the next five years.Factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improvements and modernization of  healthcare infrastructure, government initiatives to have advan......
  • 2014-2018 Germany Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
    Published: 12-Nov-2014        Price: US $3000 Onwards        Pages: 121
    This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments Abbott Affymetrix Agilent Technologies Applied Gene Tech......
  • 2014-2018 Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers–Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies
    Published: 12-Nov-2014        Price: US $8500 Onwards        Pages: 500
    "New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape" is Venture Planning Group's new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Rationale The growing economic pressures on hos......
  • 2014-2018 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies
    Published: 12-Nov-2014        Price: US $2450 Onwards        Pages: 410
    This new study from Venture Planning Group contains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testig for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights Market shares of leading suppliers Business and technological trends in major markets Five-year test volume and sa......
  • 2014-2018 World Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country
    Published: 12-Nov-2014        Price: US $2450 Onwards        Pages: 15
    This report provides: Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country. Five-year test volume and sales forecasts by country. ......
  • 2014-2018 French Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies–Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
    Published: 12-Nov-2014        Price: US $6700 Onwards        Pages: 850
    This report presents a comprehensive analysis of the French molecular diagnostics market, including: Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test vo......
  • 2014-2018 UK Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
    Published: 12-Nov-2014        Price: US $4350 Onwards        Pages: 615
    This new study from Venture Planning Group contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of lea......
  • 2014-2018 Italy Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
    Published: 12-Nov-2014        Price: US $3000 Onwards        Pages: 121
    This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new  products in R&D, collaborative arrangements, and business strategies. Competitive Assessments Abbott Affymetrix Agilent Technologies Applied Gene Tech......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs